Environmental Nanoparticles Are Significantly over-Expressed in Acute Myeloid Leukemia: a Novel Pathogenetic Cofactor?
Authors: Visani Giuseppe , Manti Anita , Valentini Laura , Canonico Barbara , Loscocco Federica , Isidori Alessandro , Gabucci Elisa , Gobbi Pietro , Montanari Stefano , Rocchi Marco , Papa Stefano , Gatti Maria Antonietta 
Published: October 2019

Background: Continuing growth in the incidence of leukemia suggests a possible environmental etiology correlated to the increase of environmental pollution. Recently, environmental particulate pollution (EPP) has been declared by IARC a Class I carcinogenic agent; it looks reasonable to presume that not only chemicals like benzene and its derivatives, but also other components like EPP could be worth of study. No specific researches have up to now focused the role of EPP on acute myeloid leukemia; we thus have identified a suitable instrumentation and protocol to show the presence and composition of particulate matter in blood samples of patients affected by acute myeloid leukemia patients and in healthy controls.

Methods: 38 peripheral blood samples (19 acute myeloid leukemia, 19 healthy controls) were analyzed by means of an Environmental Scanning Electron Microscopy (ESEM) coupled with an Energy Dispersive Spectroscopy (EDS) a sensor capable of identifying the composition of micro- and nano-particles of exogenous nature in pathological tissues (applied for the first time in the current study on blood samples). The results were statistically treated with unpaired two-tailed Student's t-test, MANOVA and Principal Component Analysis.

Results: A consistent quantity of micron-, submicron- and nano-sized foreign bodies (from 20 micron down to 100nm) was documented in 18/19 AML cases, whereas they were absent or rare in the controls. The particles appeared as singlet and aggregates (ranging from 5 to 20micron), either in close contact with blood elements or interacting with plasma. Some reacted with blood proteins thus forming composite clusters. A total of 141 aggregates (median 8, range 0-18) in AML, compared to a total of 12 aggregates in controls (median 1, range 0-3) were counted. The aggregate analysis showed variable sizes and number of particles, with a total of 5394 particles in leukemia cases compared to a total of 207 in controls. The total numbers of aggregates and particles were statistically different between cases and controls (MANOVA, P<0.001 e P=0.009 respectively). Aggregates were then analyzed with EDS, identifying their elemental composition. The particles mostly contained highly reactive metals, and appeared not biocompatible and not biodegradable. In particular, micro- and nano-sized particulates were segregated in organic-inorganic clusters, with statistically higher frequency of a subgroup of elements in AML samples (Si, P=0.03; Al, P=0.03; Fe, P=0.002; Ti, P=0.04, Cu, P=0.02, respectively). The analyses of the chemical spectra in some cases allowed to recognize and identify the source of the contamination.

Conclusion: In conclusion, we demonstrated the exposure of a subset of AML patients to environmental contaminants, with invasive character in the human body, not biocompatible and biopersistent. AML, as well as myelodysplastic syndromes, are derived from precursor cells critical in innate immunity, that submicronic particles could have triggered. New etiopathogenic hypotheses involving an interaction among sub-micron and nanosized particles with blood components are under evaluation.

Disclosures

No relevant conflicts of interest to declare.